MP Nucleic Acid Test Kit (PCR- fluorescence probe method) User Instruction Manual
Contact us for pricing - info@breakwatersci.com
For research use only
PACKAGE SPECIFICATION
48T/Kit
INTENDED USE
This kit is intended for in vitro qualitative detection of Mycoplasma pneumonia (MP) nucleic acid in human oropharyngeal swabs specimens.
Mycoplasma pneumoniae starts slowly, with symptoms such as sore throat, headache, fever, fatigue, muscle aches, loss of appetite, nausea and vomiting at the beginning of the illness. The onset of fever is usually moderate, and respiratory symptoms are obvious after 2-3 days, highlighted by a paroxysmal irritating cough, especially at night, with a small amount of mucous or mucopurulent sputum, sometimes with blood in the sputum, and also dyspnoea and chest pain. Humans are generally susceptible to Mycoplasma pneumoniae, mainly in preschool-aged, school-aged children and adolescents.
Mycoplasmas are the smallest known independent pathogenic microorganisms between bacteria and viruses. The p1 gene is the most widely studied gene in Mycoplasma pneumoniae, with a size of approximately 4900 bases. Mycoplasma pneumoniae is divided into type 1 and type 2 strains according to the differences in the p1 gene sequence.
This kit is suitable for the auxiliary diagnosis of Mycoplasma pneumoniae infection, clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Negative results must be combined with clinical observations, patient history, and epidemiological information to make decision.
This kit is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro molecular diagnostic procedures.
This kit is for in vitro diagnostic use only.
Contact us for pricing - info@breakwatersci.com
For research use only
PACKAGE SPECIFICATION
48T/Kit
INTENDED USE
This kit is intended for in vitro qualitative detection of Mycoplasma pneumonia (MP) nucleic acid in human oropharyngeal swabs specimens.
Mycoplasma pneumoniae starts slowly, with symptoms such as sore throat, headache, fever, fatigue, muscle aches, loss of appetite, nausea and vomiting at the beginning of the illness. The onset of fever is usually moderate, and respiratory symptoms are obvious after 2-3 days, highlighted by a paroxysmal irritating cough, especially at night, with a small amount of mucous or mucopurulent sputum, sometimes with blood in the sputum, and also dyspnoea and chest pain. Humans are generally susceptible to Mycoplasma pneumoniae, mainly in preschool-aged, school-aged children and adolescents.
Mycoplasmas are the smallest known independent pathogenic microorganisms between bacteria and viruses. The p1 gene is the most widely studied gene in Mycoplasma pneumoniae, with a size of approximately 4900 bases. Mycoplasma pneumoniae is divided into type 1 and type 2 strains according to the differences in the p1 gene sequence.
This kit is suitable for the auxiliary diagnosis of Mycoplasma pneumoniae infection, clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Negative results must be combined with clinical observations, patient history, and epidemiological information to make decision.
This kit is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro molecular diagnostic procedures.
This kit is for in vitro diagnostic use only.
Contact us for pricing - info@breakwatersci.com
For research use only
PACKAGE SPECIFICATION
48T/Kit
INTENDED USE
This kit is intended for in vitro qualitative detection of Mycoplasma pneumonia (MP) nucleic acid in human oropharyngeal swabs specimens.
Mycoplasma pneumoniae starts slowly, with symptoms such as sore throat, headache, fever, fatigue, muscle aches, loss of appetite, nausea and vomiting at the beginning of the illness. The onset of fever is usually moderate, and respiratory symptoms are obvious after 2-3 days, highlighted by a paroxysmal irritating cough, especially at night, with a small amount of mucous or mucopurulent sputum, sometimes with blood in the sputum, and also dyspnoea and chest pain. Humans are generally susceptible to Mycoplasma pneumoniae, mainly in preschool-aged, school-aged children and adolescents.
Mycoplasmas are the smallest known independent pathogenic microorganisms between bacteria and viruses. The p1 gene is the most widely studied gene in Mycoplasma pneumoniae, with a size of approximately 4900 bases. Mycoplasma pneumoniae is divided into type 1 and type 2 strains according to the differences in the p1 gene sequence.
This kit is suitable for the auxiliary diagnosis of Mycoplasma pneumoniae infection, clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Negative results must be combined with clinical observations, patient history, and epidemiological information to make decision.
This kit is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro molecular diagnostic procedures.
This kit is for in vitro diagnostic use only.